Investor Relations · $167M. FY'23 Revenue. 7% YtY growth · $25-30M. Adj. EBITDA expected in 2024. >75%. Adj. EBITDA growth YtY · $73M. Cash balance. with no ...
People also ask
What does investor relations do?
Who is the CEO of Anika Therapeutics?
Investors. We are committed to enhancing shareholder value through sustained profitable growth in early intervention orthopedics.
Anika Therapeutics Inc. Common Stock (ANIK) Earnings Report Date
www.nasdaq.com › ... › Stocks › ANIK
Find annual and quearterly earnings data for Anika Therapeutics Inc. Common Stock (ANIK) including earnings per share, earnings forecasts at Nasdaq.com.
Results” tab in the Investor Relations section of the Company's website at www.anika.com. ... ANIKA SNAPSHOT (NASDAQ: ANIK). 3. RESTORING ACTIVE LIVING FOR PEOPLE ...
6 days ago · For Investor Inquiries: Anika Therapeutics, Inc. Mark Namaroff, 781-457-9287. Vice President, Investor Relations, ESG and Corporate ...
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings ...
finance.yahoo.com › news › anika-thera...
Mar 16, 2024 · Our earnings press release was issued after the close of the market today and is available on our Investor Relations website located at www.
Discover real-time Anika Therapeutics Inc. Common Stock (ANIK) stock prices, quotes, historical data, news, and Insights for informed trading and investment ...